Altered prevalence of human parvovirus B19 component genes in systemic sclerosis skin tissue [11]

British Journal of Dermatology

Volumn 152, Issue 5, 2005, Pages 1078-1080

  Ohtsuka, T ^a   Yamazaki, S ^a  

^a DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GEL ELECTROPHORESIS; GENE IDENTIFICATION; GENOTYPE; HUMAN; HUMAN TISSUE; LETTER; MALE; NS1 GENE; PARVOVIRUS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; VIRUS GENE; VP1 GENE; VP2 GENE;

ADULT; AGED; DNA, VIRAL; FEMALE; GENES, VIRAL; HUMANS; MALE; MIDDLE AGED; PARVOVIRUS B19, HUMAN; SCLERODERMA, SYSTEMIC;

EID: 18944383475     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06567.x     Document Type: Letter

References (7)

1. Ohtsuka T, Yamazaki S. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin. Br J Dermatol 2004; 150:1091-5.
2. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581-90.
3. Hokynar K, Brunstein J, Soderlund-Venermo M et al. Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue. J Gen Virol 2000; 81:1017-25.
4. Hokynar K, Soderlund-Venermo M, Pesonen M et al. A new parvovirus genotype persistent in human skin. Virology 2001; 301:114-8.
5. Blundell MC, Beard C, Astell CR. In vitro identification of a B19 parvovirus promoter. Virology 1987; 157:534-8.
6. Kajigaya S, Shimada T, Fujita S et al. A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus. Proc Natl Acad Sci USA 1989; 86:7601-5.
7. Ray NB, Nieva DR, Seftor EA et al. Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibroblasts. Arthritis Rheum 2001; 44:1582-6.